Notification in terms of Section 122(3) of the Companies Act and Paragraph 3.83(b) of the JSE Listings Requirements ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) ("Aspen Holdings" or "Company") Registration number: 1985/002935/06 Share code: APN ISIN: ZAE000066692 LEI: 635400ZYSN1IRD5QWQ94 and its subsidiaries (collectively "Aspen" or "the Group") NOTIFICATION IN TERMS OF SECTION 122(3) OF THE COMPANIES ACT AND PARAGRAPH 3.83(B) OF THE JSE LISTINGS REQUIREMENTS In accordance with section 122(3)(b) of the Companies Act, No. 71 of 2008 ("the Act") and paragraph 3.83(b) of the JSE Listings Requirements, holders of ordinary shares in the Company are advised that the Public Investment Corporation SOC Limited ("PIC") has formally notified the Company that it has increased its beneficial interest in the securities of the Company to 20.157% of the ordinary share capital of the Company, effective 7 February 2025. Aspen has filed the notice with the Takeover Regulation Panel as required in terms of section 122(3)(a) of the Act. The board of directors accepts responsibility for the information contained in this announcement, and to the best of their knowledge and belief, that information is true, and this announcement does not omit anything likely to affect the importance of the information included. Durban 12 February 2025 Sponsor: Investec Bank Limited Date: 12-02-2025 10:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.